ClinicalTrials.gg
Sign In
CompletedNCT05213247Updated Jan 28, 2022

Effect of Khat Chewing on Blood Pressure and Heart Rate Among Healthy Adults

An observational study in Blood Pressure and Heart Rate, sponsored by Aljanad University for Science and Technology. Completed at 1 site in Yemen. Open to participants aged 15 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-01-28.

Sponsored by Aljanad University for Science and Technology · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
100
Ages
15 Years to 65 Years
Sex
All
01

Study summary

This study is a cross sectional study

Read the detailed description

Objective: This study aims to investigate .ht short-term effect of khat on the diastolic and systolic blood pressure (DBP, SBP) and heart rate (HR) of yemeni adults. Factors associated with Khat chewing and Khat-dependence were also investigated. That the khat chewing is a growing public habit among yemeni people.

02

Conditions studied

  • Blood Pressure
  • Heart Rate

Keywords

  • Khat-SDS
  • Blood Pressure
  • Heart Rate
03

In context

Lead sponsor

This is the only study on the registry with Aljanad University for Science and Technology as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

This is a cross-sectional study conducted from April to September 2021 in Taiz, Yemen. 100 healthy adults were selected using a random sampling method.

Eligibility criteria

The participant should be free of any disease and should avoid eating or drinking anything that could affect on BP and HR within two khat before hours chewing (zero time)

05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
100 participants (actual)
Patient registry
No

Interventions

  • Deviceelectronic apparatus (visocor OM50).

    Measurement of blood pressure and heart rate

06

What researchers measure

Primary outcomes

  1. Blood Pressure

    Elevation of blood pressure due to khat Chewing

    Time frame: April- December 2021

07

Study locations

1 site
  • Mujeeb Sultan
    Ta‘izz, 04, Yemen
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Apr 2021 to primary completion in Dec 2021, 8 months.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 30, 2021
First posted
Jan 28, 2022
StartActual
Apr 1, 2021
Primary completionActual
Dec 1, 2021
CompletionActual
Dec 1, 2021
Last update
Jan 28, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 28, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05213247
Lead sponsor
Aljanad University for Science and Technology
Responsible party
Mujeeb Abdullah Saeed Sultan (Head of Pharmacy Department, Aljanad University for Science and Technology) — Principal investigator
First posted
Jan 28, 2022
Start date
Apr 1, 2021
Primary completion
Dec 1, 2021
Completion
Dec 1, 2021
Last update
Jan 28, 2022

Study contacts

Mujeeb Sultan
principal investigator · Aljanad University for Science and Technology

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion